Ana Lúıza Gibertoni Cruz

Statistics

Publications

Citations

501

H-Index

Active since

2015

Affiliations

University of Oxford(Current)

John Radcliffe Hospital

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Istituti di Ricovero e Cura a Carattere Scientifico

Vita-Salute San Raffaele University

Ana Lúıza Gibertoni Cruz is an author at University of Oxford specializing in phenotypic drug susceptibility testing, mycobacterium tuberculosis infection, and antibiotic resistance.

ORCID

Publications per year

2015–2024

Publications

Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis

Paola M. V. Rancoita, Federica Cugnata, Ana Lúıza Gibertoni Cruz et al. · Antimicrobial Agents and Chemotherapy · 2018 · 83 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +13

Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis

Lindsay Sonnenkalb, Joshua James Carter, Andrea Spitaleri et al. · The Lancet Microbe · 2023 · 78 citations · Full text

Life Sciences, Bioinformatics, Pharmacology +17

DeepAMR for predicting co-occurrent resistance of <i>Mycobacterium tuberculosis</i>

Yang Yang, A Sarah Walker, Daniel J. Wilson et al. · Bioinformatics · 2019 · 69 citations · Full text

Life Sciences, Bioinformatics, Pharmacology +16

GenomegaMap: Within-Species Genome-Wide dN/dS Estimation from over 10,000 Genomes

Daniel J. Wilson, Derrick W. Crook, Tim Peto et al. · Molecular Biology and Evolution · 2020 · 55 citations · Full text

Life Sciences, Biology, Genetics +15

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region

Viola Dreyer, Ayan Mandal, Prachi Dev et al. · Genome Medicine · 2022 · 48 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17

1–5 of 11